Maze Therapeutics CSBO Atul Dandekar sold 6,434 shares at prices ranging from $25.81 to $27.12 per share across separate transactions. After the sales, Dandekar owned 32,316 Maze Therapeutics shares, giving investors the reported post-transaction holding for the company’s chief scientific and Business officer.

Key Highlights

  • The transactions occurred between Sep. 2 and Sep. 3, 2026.
  • Sale prices ranged from $25.81 to $27.12 per share.
  • Atul Dandekar retained 32,316 Maze Therapeutics shares.

Maze Therapeutics, Inc. (NASDAQ: MAZE) shares sold by CSBO Atul Dandekar totaled 6,434 across separate transactions. The sales left Dandekar with 32,316 shares, establishing his reported remaining position after the transactions.

Sale Prices Spanned $25.81 to $27.12

Dandekar’s transactions took place between Sep. 2 and Sep. 3, 2026. Each transaction used the S transaction code, and the reported prices ranged from $25.81 to $27.12 per share. Maze Therapeutics identified Dandekar as its CSBO. Following the transactions, his ownership stood at 32,316 shares of Maze Therapeutics. The sales involved 6,434 Maze Therapeutics shares. The reported post-transaction balance was 32,316 shares.